54
Views
13
CrossRef citations to date
0
Altmetric
Original Research

NANOG as an adverse predictive marker in advanced non–small cell lung cancer treated with platinum-based chemotherapy

, , , , &
Pages 4625-4633 | Published online: 19 Sep 2017

Reprints and Permissions

Permission is granted subject to the terms of the License under which the work was published. Permission will be required if your reuse is not covered by the terms of the License.

To request a reprint or commercial or derivative permissions for this article, please click on the relevant link below.

For more information please visit our Permissions help page.